Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: COVAXIN

Posted on April 9, 2021

180 deaths following COVID-19 vaccination reported in India

In all, 492 severe and serious AEFI have been classified by the AEFI Secretariat of the immunisation technical support unit (ITSU) at the Health Ministry. Classification has been completed for…

Continue Reading
Posted on April 5, 2021April 5, 2021

Health Ministry reveals the names of SEC members for vaccine approval

Names of the ten members Dr. Varsha Gupta, Professor, Department of Microbiology, Government Medical College Hospital, Chandigarh; 2) Dr. Archana Thakur, Medical Director, Professor and HOD (Microbiology), G.B. Pant Hospital,…

Continue Reading
Posted on April 1, 2021April 1, 2021

SEC allows Bharat Biotech to unblind all participants above 45 years

The Subject Expert Committee (SEC) has permitted Bharat Biotech to unblind all phase-3 trial participants above 45 years and offer the vaccine to those who received a placebo. The reason: vaccines (including Covaxin) are already available under the immunisation programme, and therefore all the eligible age groups should be unblinded for vaccination.

Continue Reading
Posted on March 26, 2021March 26, 2021

Achieving vaccine equity by making comorbidities redundant for those above 45 years

By following the U.K. model of vaccinating people based on age bands rather than focussing on comorbidities, millions of people would become eligible to receive the vaccine and be fully…

Continue Reading
Posted on March 20, 2021

Should Covaxin trial continue till 130 cases are recorded?

According to details posted on the clinical trial registry, the company had planned to “continue the phase-3 trial until 130 study participants developed PCR-confirmed symptomatic COVID-19 disease during follow-up beginning…

Continue Reading
Posted on March 13, 2021

Will adenovirus antibodies reduce the efficacy of vector vaccines?

While it is unclear if pre-existing antibodies to adenovirus vector will affect vaccine efficacy, it is possible that repeated vaccination using adenovirus-based vaccine either as a booster or as annual vaccination, if the need arises, will result in reduced efficacy due to vector immunity.

Continue Reading
Posted on March 5, 2021March 5, 2021

Covaxin should no longer be available in ‘clinical trial mode’

The vaccine efficacy was measured based on symptomatic COVID-19 disease — mild, moderate or severe — two weeks after the second dose. The interim analysis undertaken at the first endpoint…

Continue Reading
Posted on March 1, 2021March 1, 2021

Doctors say comorbidities list for COVID-19 vaccination is highly restrictive

“The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been left out,” says Dr. Gagandeep Kang, Professor of Microbiology at…

Continue Reading

Posts navigation

Page 1 Page 2 Page 3 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,782 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • COVID-19: Protection against reinfection may last only for months April 11, 2021
  • India will add four million more cases by May 1, says Giridhara Babu April 10, 2021
  • 180 deaths following COVID-19 vaccination reported in India April 9, 2021
  • Health Ministry reveals the names of SEC members for vaccine approval April 5, 2021
  • What is driving the second wave in India? April 3, 2021

Most Read Posts

  • IGIB: In vaccinated people, Covishield first dose is highly immunogenic if already infected
  • India will add four million more cases by May 1, says Giridhara Babu
  • COVID-19: Protection against reinfection may last only for months
  • No correlation between Ct values of PCR test and COVID-19 severity
  • 180 deaths following COVID-19 vaccination reported in India
  • UGC’s revised white list has 71 active predatory journals
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,782 other followers

Archives

Cancel

 
Loading Comments...
Comment
    ×